These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 20021566
1. D3 dopamine receptor signals to activation of phospholipase D through a complex with Rho. Everett PB, Senogles SE. J Neurochem; 2010 Feb; 112(4):963-71. PubMed ID: 20021566 [Abstract] [Full Text] [Related]
4. Binding of Cdc42 to phospholipase D1 is important in neurite outgrowth of neural stem cells. Yoon MS, Cho CH, Lee KS, Han JS. Biochem Biophys Res Commun; 2006 Sep 01; 347(3):594-600. PubMed ID: 16842757 [Abstract] [Full Text] [Related]
5. AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity. Andresen BT, Shome K, Jackson EK, Romero GG. Am J Physiol Renal Physiol; 2005 Apr 01; 288(4):F763-70. PubMed ID: 15572519 [Abstract] [Full Text] [Related]
8. Regulation of parathyroid hormone-stimulated phospholipase D in UMR-106 cells by calcium, MAP kinase, and small G proteins. Singh AT, Bhattacharyya RS, Radeff JM, Stern PH. J Bone Miner Res; 2003 Aug 01; 18(8):1453-60. PubMed ID: 12929934 [Abstract] [Full Text] [Related]
9. The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Senogles SE. Mol Pharmacol; 2000 Aug 01; 58(2):455-62. PubMed ID: 10908315 [Abstract] [Full Text] [Related]
14. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. Collo G, Zanetti S, Missale C, Spano P. Eur J Neurosci; 2008 Oct 01; 28(7):1231-40. PubMed ID: 18973551 [Abstract] [Full Text] [Related]
15. Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways. Notcovich C, Diez F, Tubio MR, Baldi A, Kazanietz MG, Davio C, Shayo C. Exp Cell Res; 2010 Feb 01; 316(3):401-11. PubMed ID: 19913013 [Abstract] [Full Text] [Related]
16. Lack of discrimination by agonists for D2 and D3 dopamine receptors. Burris KD, Pacheco MA, Filtz TM, Kung MP, Kung HF, Molinoff PB. Neuropsychopharmacology; 1995 Jul 01; 12(4):335-45. PubMed ID: 7576010 [Abstract] [Full Text] [Related]
17. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS. J Biol Chem; 2007 Dec 07; 282(49):35842-54. PubMed ID: 17923483 [Abstract] [Full Text] [Related]
18. Determination of interaction sites on the small G protein RhoA for phospholipase D. Bae CD, Min DS, Fleming IN, Exton JH. J Biol Chem; 1998 May 08; 273(19):11596-604. PubMed ID: 9565577 [Abstract] [Full Text] [Related]
19. Signalling components involved in the coupling of alpha 1-adrenoceptors to phospholipase D in neonatal rat cardiac myocytes. Gosau N, Fahimi-Vahid M, Michalek C, Schmidt M, Wieland T. Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun 08; 365(6):468-76. PubMed ID: 12070761 [Abstract] [Full Text] [Related]
20. Enhanced phospholipase D activity and altered morphology in RhoA-overexpressing RAT1 fibroblasts. Malcolm KC, Sable CL, Elliott CM, Exton JH. Biochem Biophys Res Commun; 1996 Aug 14; 225(2):514-9. PubMed ID: 8753793 [Abstract] [Full Text] [Related] Page: [Next] [New Search]